Investor's Business Daily on MSN
Axsome Therapeutics stock jumps after FDA grants priority review for Alzheimer's agitation drug
Axsome stock jumped Wednesday after the biotech firm said its Alzheimer's disease agitation drug will get a priority review.
Many men appear stable yet experience deep emotional loneliness. This article explores how loneliness affects mental health.
An analysis of political violence in West Bengal, drawing unsettling parallels with Bangladesh’s democratic collapse.
Explore how nanotechnology acts as the 'Convergence Engine' for AI materials discovery, CRISPR gene therapy delivery, and ...
Morning Overview on MSN
1 gene explains how inflammation can push kidneys toward failure
Inflammation has long been a warning sign in kidney clinics, a red flag that often appears years before a patient tips into ...
Objective To characterise the age-related impact of organ damage patterns on health-related quality of life (HRQoL) in ...
The data mining tools market is set to expand to USD 3.89 billion by 2034, registering a 12.30% CAGR as data-driven ...
Your brain doesn't have to age on autopilot. New research shows we can slow—and potentially reverse—brain aging.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results